Explore
Validate
LearnPAB4883
antibody from Abnova Corporation
Targeting: YBX1
BP-8, CSDA2, CSDB, DBPB, MDR-NF1, NSEP-1, NSEP1, YB-1, YB1
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PAB4883 - Provider product page
- Provider
- Abnova Corporation
- Proper citation
- Abnova Corporation Cat#PAB4883, RRID:AB_1580103
- Product name
- YBX1 polyclonal antibody
- Antibody type
- Polyclonal
- Description
- Rabbit polyclonal antibody raised against synthetic peptide of YBX1.
- Storage
- Store at 4°C. For long term storage store at -20°C.Aliquot to avoid repeated freezing and thawing.
Submitted references Y-box protein-1 controls transforming growth factor-beta1 translation in proximal tubular cells.
Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
Twist promotes tumor cell growth through YB-1 expression.
Fraser DJ, Phillips AO, Zhang X, van Roeyen CR, Muehlenberg P, En-Nia A, Mertens PR
Kidney international 2008 Mar;73(6):724-32
Kidney international 2008 Mar;73(6):724-32
Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
Fujii T, Kawahara A, Basaki Y, Hattori S, Nakashima K, Nakano K, Shirouzu K, Kohno K, Yanagawa T, Yamana H, Nishio K, Ono M, Kuwano M, Kage M
Cancer research 2008 Mar 1;68(5):1504-12
Cancer research 2008 Mar 1;68(5):1504-12
Twist promotes tumor cell growth through YB-1 expression.
Shiota M, Izumi H, Onitsuka T, Miyamoto N, Kashiwagi E, Kidani A, Yokomizo A, Naito S, Kohno K
Cancer research 2008 Jan 1;68(1):98-105
Cancer research 2008 Jan 1;68(1):98-105
No comments: Submit comment
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Western blot analysis of YBX1 (arrow) using rabbit YBX1 polyclonal antibody (Cat # PAB4883). 293 cell lysate (2 ug/lane) either nontransfected (Lane 1) or transiently transfected with the YBX1 gene (Lane 2) (Origene Technologies).
